Navigation Links
LifeVantage to Present at Rodman & Renshaw Annual Global Investment Conference
Date:8/31/2011

SALT LAKE CITY, Aug. 31, 2011 /PRNewswire/ -- LifeVantage Corporation (OTCBB: LFVN), makers of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, announced today that Douglas C. Robinson, the Company's President and Chief Executive Officer, and Dr. Joe McCord, the Company's Chief Science Officer, will be presenting at the Rodman & Renshaw Annual Global Investment Conference, to be held on September 11-13, 2011, at the Waldorf Astoria in New York.

(Logo: http://photos.prnewswire.com/prnh/20090930/LIFEVANTAGELOGO)  

The LifeVantage investor presentation is scheduled for Tuesday, September 13, 2011, at 9:10 am Eastern Time.  The presentation will be webcast live and archived at www.LifeVantage.com. Visitors to the website should select the "Investor Info" link to access the webcast.

At the Rodman & Renshaw Annual Global Investment Conference, more than 520 public & private companies from around the world are registered to present in front of an audience of over 4,000 attendees. The conference will feature tracks devoted to Healthcare, China, Metals & Mining, Energy, Technology, Cleantech, Financial Services, Israel and Growth/Special Situations. Al Gore, 45th Vice President of the United States, will open the Conference as the Keynote Speaker on Monday, September 12, 2011. Additional highlights of the conference include a speech by Henry Kissinger, 56th United States Secretary of State, who will address the audience as a special Guest Speaker on Tuesday, September 13, 2011. Dr. Kissinger's speech will be followed by corporate presentations, Q & A sessions, investor one-on-one meetings and daily networking opportunities.

About LifeVantage Corporation

LifeVantage, (OTCBB: LFVN), makers of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, is a science based nutraceutical company. LifeVantage is dedicated to visionary science that promises to transform wellness and anti-aging internally and externally with supplements that dramatically reduce oxidative stress at the cellular level. The Company was founded in 2003 and currently has operations in Salt Lake City, Utah and San Diego, CA. For more information, visit www.LifeVantage.com.

Investor Relations Contact:
Cindy England (801) 432-9036
Director of Investor Relations
-or-
John Mills (310) 954-1105
Senior Managing Director, ICR, LLC


'/>"/>
SOURCE LifeVantage Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. LifeVantage Announces Preliminary Third Quarter 2011 Revenue
2. LifeVantage Announces Settlement of Zrii Litigation
3. LifeVantage Announces Unaudited First Quarter Fiscal 2010 Financial and Operating Results
4. LifeVantage Announces Preliminary Unaudited First Quarter Revenue
5. LifeVantage Announces Fourth Quarter and Fiscal Year 2009 Financial and Operating Results
6. Echo Therapeutics to Present at the Stifel Nicolaus Healthcare Conference 2011
7. BioDelivery Sciences Announces Upcoming Presentations at Three Investor Conferences
8. Elbit Imaging Announces Availability of Investor Relations Presentation - Analysis Sources and Uses
9. Inovio Pharmaceuticals to Present at Investor Conferences
10. Watson to Present at the 2011 Morgan Stanley Global Healthcare Conference
11. Luminex Corporation to Present at Upcoming Investment Conferences In September
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... Calif. , Oct. 10, 2017  NDS received FDA 510(k) ... — a medical-grade battery-powered display stand specifically designed for endoscopy environments. ... transform technology into a clinical solution to support the improvement of ... Innovative Design ... Mobile Wireless Solution ...
(Date:10/5/2017)... 2017  In response to the nationwide opioid ... Surgeons (AAOMS) released prescribing recommendations that urge ibuprofen ... as a first-line therapy to manage a patient,s ... Recognizing the value and importance of ... Prescribing: Acute and Postoperative Pain Management" stresses that ...
(Date:10/4/2017)... 4, 2017 OBP Medical , ... medical devices, today announced regulatory approval from ... (or Agência Nacional de Vigilância Sanitária (ANVISA)) to ... surgical retractor with integrated LED light source and ... and exposure of a tissue pocket or cavity ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) ... FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... Morris F. Collen, a pioneer in the field of medical informatics, this prestigious award ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader ... a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were ... 11, 2017. , The annual award competition recognizes editorial and design excellence across a ...
Breaking Medicine News(10 mins):